Geode Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-183,207
| Closed | -$24.1M | – | 4526 |
|
|
2020
Q4 | $24.1M | Buy |
183,207
+10,633
| +6% | +$1.4M | ﹤0.01% | 1601 |
|
|
2020
Q3 | $8.72M | Buy |
172,574
+27,226
| +19% | +$1.38M | ﹤0.01% | 2028 |
|
|
2020
Q2 | $6.93M | Buy |
145,348
+3,805
| +3% | +$181K | ﹤0.01% | 2150 |
|
|
2020
Q1 | $6.93M | Buy |
141,543
+19,238
| +16% | +$942K | ﹤0.01% | 1950 |
|
|
2019
Q4 | $7.02M | Buy |
122,305
+2,237
| +2% | +$128K | ﹤0.01% | 2246 |
|
|
2019
Q3 | $4.32M | Sell |
120,068
-3,707
| -3% | -$133K | ﹤0.01% | 2467 |
|
|
2019
Q2 | $3.85M | Sell |
123,775
-1,488
| -1% | -$46.2K | ﹤0.01% | 2556 |
|
|
2019
Q1 | $2.94M | Buy |
125,263
+45,242
| +57% | +$1.06M | ﹤0.01% | 2617 |
|
|
2018
Q4 | $1.1M | Buy |
80,021
+48,659
| +155% | +$669K | ﹤0.01% | 3076 |
|
|
2018
Q3 | $312K | Buy |
+31,362
| New | +$312K | ﹤0.01% | 3616 |
|